Re: Why now?
in response to
by
...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Message: Re: Why now?
Your Vote:
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Actually Koo I have not really been paying attention at all. Have yet to check out the AGM. Figure I got a boat load of free shares and if something happens I will let it be a surprise as got enough disappointments with the other. Lol.
CCD
Loading...
Loading...
New Message
Please
login
to post a reply